Severe asthma and its associated factors
Article Sidebar
Main Article Content
Abstract
Objective: Conduct a review on the severity of asthma and its associated factors. Bibliographic review: Asthma is, by definition, a chronic airway disease characterized by chronic inflammation, variable obstruction of the lower airways, and bronchial hyperresponsiveness. It can be classified in severity from STEP 1 to STEP 5. Severe asthma is the most aggressive form of chronic airway inflammatory disease and has a complex nature with constant innovations in pharmacological management, including significant advances in phenotyping and the use of biomarkers. Final considerations: Asthma is a prevalent disease that, when uncontrolled, can lead to serious emergencies requiring correct and urgent therapeutic management for symptom relief and effective return of lung function. Controlling the overall condition of the patient helps prevent major complications such as permanent changes in lung function, difficulty breathing leading to the need for ventilation, hospitalization, and admission. In this regard, controlling severe asthma and difficult-to-control asthma is essential to providing a quality of life for patients.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. CLOUTIER MM, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol, 2020; 146(6): 1217-1270.
3. ELLIOTT MR, et al. An Update on Monoclonal Antibody Therapy to Treat Moderate-to-Severe Asthma: Benefits, Choices, and Limitations. Am J Med, 2023; 136(8): 738-744.
4. GINA. Global Strategy for Asthma Management and Prevention, 2023; 1: 246.
5. KARDAS G, et al. Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling. Front Immunol, 2020; 11: 1134.
6. LOMMATZSCH M, BUHL R. The Treatment of Mild and Moderate Asthma in Adults. Dtsch Arztebl Int, 2020; 117(25): 434-444.
7. MANGARAVITI RB, et al. Fatores e impactos associados à asma e rinite alérgica na qualidade de vida – uma revisão da literatura. Brazilian Journal of Health Review, 2021; 4(2): 5131-5142.
8. NETO FARS, et al. Asma e seus aspectos fisiopatológicos: revisão integrativa da literatura. Research, Society and Development, 2022; 11(14): e186111436267.
9. PATEL SJ, TEACH SJ. Asthma. Pediatr Rev, 2019; 40(11): 549-567.
10. PEREIRA GNV, et al. Revisão de literatura e relato de caso: asma brônquica. Revista de Ciências Biológicas e da Saúde, 2023; 14-19.
11. PINTO RMC, et al. 2021 Brazilian Thoracic Association recommendations for the management of severe asthma. J Bras Pneumol, 2021; 47(6): e20210273.
12. PIZZICHINI MMM, et al. Recomendações para o manejo da asma da Sociedade Brasileira de Pneumologia e Tisiologia - 2020. J Bras Pneumol, 2020; 46(1): e20190307.
13. PONTE EV, SOUZA-MACHADO A. Asma grave no Brasil: do diagnóstico ao tratamento. J Bras pneumol, 2021; 47(06): e20210386.
14. RAMALHO I, BARROS R. Asma - Diferenças entre os gêneros. Salutis Scientia - Revista de Ciências da Saúde da ESSCVP, 2022; 14: 13-25.
15. RODRIGUES AS, et al. Abordagem geral da asma: uma revisão narrativa. Revista Eletrônica Acervo Médico, 2021; 1(2): e9129.
16. SANTINI JX, et al. Asma brônquica: uma revisão de literatura. Brazilian Journal of Health Review, 2023; 6(4): 18355-18365.
17. SILVA MTO, et al. Uso de imunobiológicos no manejo da asma grave em pediatria. Revista Eletrônica Acervo Médico, 2021; 13(9): e8150.
18. SOARES CR. Efeito da terapia com laser de baixa intensidade em estudo clínico e experimental de asma brônquica. Tese de Doutorado (Doutorado em Biofotônica) - Programa de Pós-Graduação em Biofotônica Aplicada às Ciências da Saúde. Universidade Nove de Julho (UNINOVE), São Paulo, 2018; 1: 102.
19. SULAIMAN I, GAUVREAU GM. Terapias antialarminas para a asma: para onde vamos a partir daqui?. J Bras Pneumol, 2023; 49(3): e 20230220.
20. WENZEL SE. Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes. Am J Respir Crit Care Med, 2021; 203(7): 809-821.